TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)
Public ClinicalTrials.gov record NCT03477903. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous TAK-954 in Critically Ill Patients With Enteral Feeding Intolerance
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the treatment effect of intravenous TAK-954 in improving the average daily protein adequacy received through enteral nutrition in critically-ill participants developing EFI.
Study identification
- NCT ID
- NCT03477903
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1 participant
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 25, 2018 (Actual)
- Primary completion
- Aug 29, 2018 (Actual)
- Completion
- Aug 29, 2018 (Actual)
- Last update posted
- Sep 24, 2019
2018
United States locations
- U.S. sites
- 14
- U.S. states
- 14
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Joseph M Still Burn Centers | Augusta | Georgia | 30909 | — |
| Eastern Idaho Medical Consultants | Idaho Falls | Idaho | 83404 | — |
| Illinois Lung & Critical Care Institute | Peoria | Illinois | 61606 | — |
| University of Kentucky Health Care | Lexington | Kentucky | 40536 | — |
| Anne Arundel Medical Center | Annapolis | Maryland | 21401 | — |
| Truman Medical Center Hospital Hill | Kansas City | Missouri | 64108 | — |
| Creighton University | Omaha | Nebraska | 68124 | — |
| Englewood Hospital and Medical Center | Englewood | New Jersey | 07631 | — |
| New York-Presbyterian Columbia University Medical Center | New York | New York | 10032 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| Froedtert Hospital | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03477903, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03477903 live on ClinicalTrials.gov.